MedTrace Logo

Cervical Capsaicin for Labor Induction and Pain Relief

NCT00771511 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-08-09

No results posted yet for this study

Summary

In the setting of fetal demise it is important to help the mother deliver the fetus expeditiously and with as little physical trauma as possible. This study hypothesizes that application of capsaicin to the uterine cervix will enhance cervical ripening and desensitize pain fibers such that delivery is less painful.

Conditions

  • Labor Pain
  • Pregnancy Loss
  • Labor Induction

Interventions

DRUG

capsaicin

capsaicin cream 0.1% 10 ml applied to cervix

DRUG

Placebo

Only lidocaine gel will be appled to the cervix

Sponsors & Collaborators

Principal Investigators

  • Pamela Flood, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-06-30
Completion
2011-06-30
FDA Drug
Yes

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00771511 on ClinicalTrials.gov